The U.S. Senate on Monday again approved a bill to provide $52 billion in U.S. subsidies for semiconductor chip manufacturing in a bid to reach a compromise after months of discussions.
Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.